Collaboration and Asset Purchase Agreement Between Reata Pharmaceuticals, Inc. and CNS Pharmaceuticals, Inc.Collaboration and Asset Purchase Agreement • June 15th, 2018 • CNS Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Collaboration and Asset Purchase Agreement (the “Agreement”) is made and entered into as of November 21, 2017 (the “Effective Date”), by and between Reata Pharmaceuticals, Inc., a Delaware corporation (“Reata”), having its principal place of business at 2801 Gateway Drive, Suite 150, Irving, TX 75063 and CNS Pharmaceuticals, Inc. (“CNS”), a Nevada corporation having its principal place of business at 14405 Walters Road, Suite 781, Houston, TX 77014. Reata and CNS are each referred to herein as a “Party” and collectively as the “Parties.”
